Skip to main content
SpringerLink
Log in

The effect of testosterone itself and in combination with letrozole on bone mineral density in male rats

  • Original Article
  • Published:
Journal of Bone and Mineral Metabolism Aims and scope Submit manuscript

Abstract

Testosterone is an essential hormone to maintain bone integrity; however, the effect of aromatase enzyme in androgen-induced bone maintenance remains somewhat unclear. The present study evaluated the effect of testosterone itself and combined with letrozole, an aromatase inhibitor, on bone mineral density of male rats. Total of 48 male rats were divided into 4 equal groups (n = 12/group); sham group, O: orchiectomy, O + T: orchiectomized rats treated with testosterone, O + T + L: orchiectomized rats treated with combination of testosterone and letrozole. Bone density (BMD), bone markers, and vitamin D metabolism parameters were checked in all groups before and after the study. There was no significant difference in baseline values of these parameters, but at the end of the study there was a significant decrease in delta BMD at both lumbar and femor in orchiectomized rats in comparison with the sham group (p < 0.001, p < 0.001, respectively). Both testosterone and its combination with letrozole increased lumbar and femoral BMD of orchiectomized rats, with a higher increase in lumbar BMD in O + T group. CTX were higher in O group rats. The present study showed a major role for testosterone on BMD maintenance in male rats. However, testosterone has a potent effect on lumbar BMD, by the aromatization to estradiol.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Rachner TD, Khosla S, Hofbauer LC (2011) New horizons in osteoporosis. Lancet 377:1276

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Ahmed S, Elmantaser M (2009) Secondary osteoporosis. Calcium and bone disorders in children and adolescents, vol 16. Karger Publishers, Basel, pp 170–190

    Chapter  Google Scholar 

  3. Giusti A, Bianchi G (2015) Treatment of primary osteoporosis in men. Clin Interv Aging 10:105

    CAS  PubMed  Google Scholar 

  4. Curtis JR, McClure LA, Delzell E, Howard VJ, Orwoll E, Saag KG, Safford M, Howard G (2009) Population-based fracture risk assessment and osteoporosis treatment disparities by race and gender. J Gen Intern Med 24:956–962

    Article  PubMed  PubMed Central  Google Scholar 

  5. Feldstein AC, Nichols G, Orwoll E, Elmer PJ, Smith DH, Herson M, Aickin M (2005) The near absence of osteoporosis treatment in older men with fractures. Osteoporos Int 16:953–962

    Article  PubMed  Google Scholar 

  6. Stuermer E, Sehmisch S, Tezval M, Tezval H, Rack T, Boekhoff J, Wuttke W, Herrmann T, Seidlova-Wuttke D, Stuermer K (2009) Effect of testosterone, raloxifene and estrogen replacement on the microstructure and biomechanics of metaphyseal osteoporotic bones in orchiectomized male rats. World J Urol 27:547–555

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Lindberg MK, Movérare S, Skrtic S, Alatalo S, Halleen J, Mohan S, Gustafsson JÅ, Ohlsson C (2002) Two different pathways for the maintenance of trabecular bone in adult male mice. J Bone Miner Res 17:555–562

    Article  PubMed  Google Scholar 

  8. Maggi M, Schulman C, Quinton R, Langham S, Uhl-Hochgraeber K (2007) The burden of testosterone deficiency syndrome in adult men: economic and quality-of-life impact. J Sex Med 4:1056–1069

    Article  PubMed  Google Scholar 

  9. Rudman D, Drinka PJ, Wilsont CR, Mattson DE, Scherman F, Cuisinier MC, Schultz S (1994) Relations of endogenous anabolic hormones and physical activity to bone mineral density and lean body mass in elderly men. Clin Endocrinol 40:653–661

    Article  CAS  Google Scholar 

  10. Varsavsky M, Reyes-García R, García-Martín A, Rozas-Moreno P, Rocío G-R, Muñoz-Torres M (2014) Bone turnover markers in patients with prostate carcinoma: influence of sex steroids levels. J Bone Miner Metab 32:65–70

    Article  CAS  PubMed  Google Scholar 

  11. Carani C, Qin K, Simoni M, Faustini-Fustini M, Serpente S, Boyd J, Korach KS, Simpson ER (1997) Effect of testosterone and estradiol in a man with aromatase deficiency. N Engl J Med 337:91–95

    Article  CAS  PubMed  Google Scholar 

  12. Seidlova-Wuttke D, Stuermer K, Stuermer E, Sehmisch S, Wuttke W (2006) Contrasting effects of estradiol, testosterone and of a black cohosh extract on density, mechanical properties and expression of several genes in the metaphysis of the tibia and on fat tissue of orchidectomized rats. Maturitas 55:S64–S74

    Article  CAS  Google Scholar 

  13. Matsumoto C, Inada M, Toda K, Miyaura C (2006) Estrogen and androgen play distinct roles in bone turnover in male mice before and after reaching sexual maturity. Bone 38:220–226

    Article  CAS  PubMed  Google Scholar 

  14. Murata Y, Robertson K, Jones M, Simpson E (2002) Effect of estrogen deficiency in the male: the ArKO mouse model. Mol Cell Endocrinol 193:7–12

    Article  CAS  PubMed  Google Scholar 

  15. Batra GS, Hainey L, Freemont AJ, Andrew G, Saunders PT, Hoyland JA, Braidman IP (2003) Evidence for cell-specific changes with age in expression of oestrogen receptor (ER) α and β in bone fractures from men and women. J Pathol 200:65–73

    Article  CAS  PubMed  Google Scholar 

  16. Nakamura T, Imai Y, Matsumoto T, Sato S, Takeuchi K, Igarashi K, Harada Y, Azuma Y, Krust A, Yamamoto Y (2007) Estrogen prevents bone loss via estrogen receptor α and induction of Fas ligand in osteoclasts. Cell 130:811–823

    Article  CAS  PubMed  Google Scholar 

  17. Basaria S, Dobs AS (2001) Hypogonadism and androgen replacement therapy in elderly men. Am J Med 110:563–572

    Article  CAS  PubMed  Google Scholar 

  18. Smith MR, McGovern FJ, Zietman AL, Fallon MA, Hayden DL, Schoenfeld DA, Kantoff PW, Finkelstein JS (2001) Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer. N Engl J Med 345:948–955

    Article  CAS  PubMed  Google Scholar 

  19. Khosla S (2004) Role of hormonal changes in the pathogenesis of osteoporosis in men. Calcif Tissue Int 75:110–113

    Article  CAS  PubMed  Google Scholar 

  20. Szulc P, Munoz F, Claustrat B, Garnero P, Marchand F, Duboeuf F, Delmas P (2001) Bioavailable estradiol may be an important determinant of osteoporosis in men: the MINOS study. J Clin Endocrinol Metab 86:192–199

    CAS  PubMed  Google Scholar 

  21. Slemenda CW, Longcope C, Zhou L, Hui SL, Peacock M, Johnston CC (1997) Sex steroids and bone mass in older men. Positive associations with serum estrogens and negative associations with androgens. J Clin Investig 100:1755

    Article  CAS  PubMed  Google Scholar 

  22. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, Williams TC, Lubahn DB, Korach KS (1994) Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 331:1056–1061

    Article  CAS  PubMed  Google Scholar 

  23. Carnevale V, Romagnoli E, Cipriani C, Del Fiacco R, Piemonte S, Pepe J, Scillitani A, Minisola S (2010) Sex hormones and bone health in males. Arch Biochem Biophys 503:110–117

    Article  CAS  PubMed  Google Scholar 

  24. Yanase T, Suzuki S, Goto K, Nomura M, Okabe T, Takayanagi R, Nawata H (2003) Aromatase in bone: roles of vitamin D3 and androgens. J Steroid Biochem Mol Biol 86:393–397

    Article  CAS  PubMed  Google Scholar 

  25. Karp NA, Meehan TF, Morgan H, Mason JC, Blake A, Kurbatova N, Smedley D, Jacobsen J, Mott RF, Iyer V (2015) Applying the ARRIVE guidelines to an in vivo database. PLoS Biol 13:e1002151

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Heydarpour F, Amini B, Kalantari S, Rostami A, Heydarpour P (2007) Determination of sensitivity of male Wistar rats to an equal dose of ketamine/xylazine injection at anesthetic dose in a chronic model of hypernatremia in comparison with control group. Saudi Med J 28:1485–1488

    PubMed  Google Scholar 

  27. Rouver WN, Delgado NTB, Menezes JB, Santos RL, Moyses MR (2015) Testosterone replacement therapy prevents alterations of Coronary vascular reactivity caused by hormone deficiency induced by castration. PLoS One 10:e0137111

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Li X, Jee W, Ke H, Mori S, Akamine T (1991) Age-related changes of cancellous and cortical bone histomorphometry in female Sprague–Dawley rats. Cells Mater 1:25

    Google Scholar 

  29. Moreau M, Libouban H, Legrand E, Baslé M, Audran M, Chappard D (2001) Lean, fat and bone masses are influenced by orchidectomy in the rat. A densitometric X-ray absorptiometric study. J Musculoskelet Neuronal Interact 1:209–213

    CAS  PubMed  Google Scholar 

  30. Bondanelli M, Ambrosio MR, Margutti A, Franceschetti P, Zatelli MC, degli Uberti EC (2003) Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone-releasing hormone. Neuroendocrinology 77:380–387

    Article  CAS  PubMed  Google Scholar 

  31. Sato T, Kawano H, Kato S (2002) Study of androgen action in bone by analysis of androgen-receptor deficient mice. J Bone Miner Metab 20:326–330

    Article  PubMed  Google Scholar 

  32. MacLean HE, Moore AJ, Sastra SA, Morris HA, Ghasem-Zadeh A, Rana K, Axell A-M, Notini AJ, Handelsman DJ, Seeman E (2010) DNA-binding-dependent androgen receptor signaling contributes to gender differences and has physiological actions in males and females. J Endocrinol 206:93–103

    Article  CAS  PubMed  Google Scholar 

  33. Fink HA, Ewing SK, Ensrud KE, Barrett-Connor E, Taylor BC, Cauley JA, Orwoll ES, Group OFiMS (2006) Association of testosterone and estradiol deficiency with osteoporosis and rapid bone loss in older men. J Clin Endocrinol Metab 91:3908–3915

    Article  CAS  PubMed  Google Scholar 

  34. Shigehara K, Konaka H, Koh E, Nakashima K, Iijima M, Nohara T, Izumi K, Kitagawa Y, Kadono Y, Sugimoto K (2017) Effects of testosterone replacement therapy on hypogonadal men with osteopenia or osteoporosis: a subanalysis of a prospective randomized controlled study in Japan (EARTH study). Aging Male 20:1–7

    Article  CAS  Google Scholar 

  35. Imai Y, Nakamura T, Matsumoto T, Takaoka K, Kato S (2009) Molecular mechanisms underlying the effects of sex steroids on bone and mineral metabolism. J Bone Miner Metab 27:127–130

    Article  CAS  PubMed  Google Scholar 

  36. Kastelan D, Grubic Z, Kraljevic I, Polasek O, Dusek T, Stingl K, Kerhin-Brkljacic V, Korsic M (2009) The role of estrogen receptor-α gene TA polymorphism and aromatase gene TTTA polymorphism on peak bone mass attainment in males: is there an additive negative effect of certain allele combinations? J Bone Miner Metab 27:198–204

    Article  CAS  PubMed  Google Scholar 

  37. Vandenput L, Ohlsson C (2009) Estrogens as regulators of bone health in men. Nat Rev Endocrinol 5(8):437–443

    Article  CAS  PubMed  Google Scholar 

  38. Bilezikian JP, Morishima A, Bell J, Grumbach MM (1999) Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency. Obstet Gynecol Surv 54:114–116

    Article  Google Scholar 

  39. Rochira V, Faustini-Fustini M, Balestrieri A, Carani C (2000) Estrogen replacement therapy in a man with congenital aromatase deficiency: effects of different doses of transdermal estradiol on bone mineral density and hormonal parameters. J Clin Endocrinol Metab 85:1841–1845

    Article  CAS  PubMed  Google Scholar 

  40. Falahati-Nini A, Riggs BL, Atkinson EJ, O’Fallon WM, Eastell R, Khosla S (2000) Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Investig 106:1553

    Article  CAS  PubMed  Google Scholar 

  41. Vanderschueren D, Van Herck E, Suiker A, Visser W, Schot L, Bouillon R (1992) Bone and mineral metabolism in aged male rats: short and long term effects of androgen deficiency. Endocrinology 130:2906–2916

    Article  CAS  PubMed  Google Scholar 

  42. Pogoda P, Priemel M, Schilling AF, Gebauer M, Catalá-Lehnenf P, Barvencik F, Beil FT, Münch C, Rupprecht M, Müldner C (2005) Mouse models in skeletal physiology and osteoporosis: experiences and data on 14839 cases from the Hamburg Mouse Archives. J Bone Miner Metab 23:97–102

    Article  PubMed  Google Scholar 

  43. Ryu S-J, Ryu D-S, Kim J-Y, Park J-Y, Kim K-H, Chin D-K, Kim K-S, Cho Y-E, Kuh S-U (2016) Changes in bone metabolism in young castrated male rats. Yonsei Med J 57:1386–1394

    Article  PubMed  PubMed Central  Google Scholar 

  44. Hale LV, Galvin RJ, Risteli J, Ma YL, Harvey AK, Yang X, Cain RL, Zeng Q, Frolik CA, Sato M, Schmidt AL, Geiser AG (2007) PINP: a serum biomarker of bone formation in the rat. Bone 40(4):1103–1109

    Article  CAS  PubMed  Google Scholar 

  45. Fekete S, Simko J, Mzik M, Karesova I, Zivna H, Pavlíková L, Palicka V (2015) Effect of mirtazapine on rat bone tissue after orchidectomy. Pharmacology 95:166–172

    Article  CAS  PubMed  Google Scholar 

  46. Francis RM, Peacock M, Aaron J, Selby P, Taylor G, Thompson J, Marshall D, Horsman A (1986) Osteoporosis in hypogonadal men: role of decreased plasma 1, 25-dihydroxyvitamin D, calcium malabsorption, and low bone formation. Bone 7:261–268

    Article  CAS  PubMed  Google Scholar 

  47. Zhang L, Chen X, Wu J, Yuan Y, Guo J, Biswas S, Li B, Zou J (2017) The effects of different intensities of exercise and active vitamin D on mouse bone mass and bone strength. J Bone Miner Metab 35:265–277

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors wish to thank Mr. H. Argasi at the Research Consultation Center (RCC) at Shiraz University of Medical Sciences for his invaluable assistance in editing this manuscript.

Funding

There is no financial support

Author information

Authors and Affiliations

  1. Shiraz Endocrinology and Metabolism Research Center, Shiraz University of Medical Sciences, P.O. Box: 71345-1744, Shiraz, Iran

    Forough Saki, Seyed Reza Kasaee, Faezeh Sadeghian, Pedram Talezadeh & Gholam Hossein Ranjbar Omrani

Authors
  1. Forough Saki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Seyed Reza Kasaee
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Faezeh Sadeghian
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pedram Talezadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gholam Hossein Ranjbar Omrani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gholam Hossein Ranjbar Omrani.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Saki, F., Kasaee, S.R., Sadeghian, F. et al. The effect of testosterone itself and in combination with letrozole on bone mineral density in male rats. J Bone Miner Metab 37, 668–675 (2019). https://doi.org/10.1007/s00774-018-0972-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00774-018-0972-6

Keywords

Search

Navigation